Table 2. Multivariate analysis for factors related to overall survival following re-WBRT.
Factor analyzed | Negative predictive factor | P value |
---|---|---|
Karnofsky performance status | ≤70 | 0.012 |
Symptoms | Severe symptoms | 0.008 |
Age | >60 | 0.901 |
Gender | 0.602 | |
Primary tumor site | Lung and others | 0.341 |
RPA class | 0.663 | |
Interval between two course of WBRT | ≤9 months | 0.733 |
BEDcumulative | >130 Gy | 0.235 |
Extracerebral metastasis | Yes | 0.229 |
Response to re-WBRT | Yes | 0.714 |
WBRT, whole brain radiation therapy; re-WBRT, re-irradiation WBRT; RPA, recursive partitioning analysis; BED, biological effective dose.